Literature DB >> 28490468

Is Tau Imaging More Than Just Upside-Down 18F-FDG Imaging?

Thilo van Eimeren1,2, Gérard N Bischof1, Alexander Drzezga3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28490468     DOI： 10.2967/jnumed.117.190082

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  10 in total

1.  D-Glucose uptake and clearance in the tauopathy Alzheimer's disease mouse brain detected by on-resonance variable delay multiple pulse MRI.

Authors:  Lin Chen; Zhiliang Wei; Kannie Wy Chan; Yuguo Li; Kapil Suchal; Sheng Bi; Jianpan Huang; Xiang Xu; Philip C Wong; Hanzhang Lu; Peter Cm van Zijl; Tong Li; Jiadi Xu
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-16       Impact factor: 6.200

Review 2.  Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Authors:  Victor L Villemagne; Vincent Doré; Samantha C Burnham; Colin L Masters; Christopher C Rowe
Journal:  Nat Rev Neurol       Date:  2018-02-16       Impact factor: 42.937

3.  [Tauopathies : From molecule to therapy].

Authors:  G G Kovacs; G Respondek; T van Eimeren; E Höller; J Levin; U Müller; S Schwarz; T W Rösler; K Schweyer; G U Höglinger
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

Review 4.  Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Authors:  Cecilia Peralta; Antonio P Strafella; Thilo van Eimeren; Roberto Ceravolo; Klaus Seppi; Valtteri Kaasinen; Julieta E Arena; Stephane Lehericy
Journal:  Mov Disord Clin Pract       Date:  2021-11-15

Review 5.  The Role of Tau Imaging in Parkinsonian Disorders.

Authors:  Jochen Hammes; Alexander Drzezga; Thilo van Eimeren
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-06       Impact factor: 5.081

6.  Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET.

Authors:  Jochen Hammes; Isabel Leuwer; Gérard N Bischof; Alexander Drzezga; Thilo van Eimeren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-12       Impact factor: 9.236

Review 7.  Imaging Markers of Progression in Parkinson's Disease.

Authors:  Antonio P Strafella; Nico I Bohnen; Nicola Pavese; David E Vaillancourt; Thilo van Eimeren; Marios Politis; Alessandro Tessitore; Christine Ghadery; Simon Lewis
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

Review 8.  An Update on the State of Tau Radiotracer Development: a Brief Review.

Authors:  Grant Rigney; Cyrus Ayubcha; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2021-05-13       Impact factor: 3.488

9.  Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison.

Authors:  Daniele Altomare; Camilla Caprioglio; Frédéric Assal; Gilles Allali; Aline Mendes; Federica Ribaldi; Kelly Ceyzeriat; Marta Martins; Szymon Tomczyk; Sara Stampacchia; Alessandra Dodich; Marina Boccardi; Christian Chicherio; Giovanni B Frisoni; Valentina Garibotto
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-27       Impact factor: 9.236

10.  Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

Authors:  Thilo van Eimeren; Angelo Antonini; Daniela Berg; Nico Bohnen; Roberto Ceravolo; Alexander Drzezga; Günter U Höglinger; Makoto Higuchi; Stephane Lehericy; Simon Lewis; Oury Monchi; Peter Nestor; Matej Ondrus; Nicola Pavese; María Cecilia Peralta; Paola Piccini; José Ángel Pineda-Pardo; Irena Rektorová; María Rodríguez-Oroz; Axel Rominger; Klaus Seppi; A Jon Stoessl; Alessandro Tessitore; Stephane Thobois; Valtteri Kaasinen; Gregor Wenning; Hartwig R Siebner; Antonio P Strafella; James B Rowe
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.